Japan Bone Grafts And Substitutes Market Size & Outlook
Japan bone grafts and substitutes market, 2018-2030 (US$M)
Related Markets
Japan bone grafts and substitutes market highlights
- The Japan bone grafts and substitutes market generated a revenue of USD 73.0 million in 2022 and is expected to reach USD 129.6 million by 2030.
- The Japan market is expected to grow at a CAGR of 7.4% from 2023 to 2030.
- In terms of segment, synthetic was the largest revenue generating material type in 2022.
- Allograft is the most lucrative material type segment registering the fastest growth during the forecast period.
Bone grafts and substitutes market data book summary
| Market revenue in 2022 | USD 73.0 million |
| Market revenue in 2030 | USD 129.6 million |
| Growth rate | 7.4% (CAGR from 2022 to 2030) |
| Largest segment | Synthetic |
| Fastest growing segment | Allograft |
| Historical data | 2017 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Allograft, Synthetic |
| Key market players worldwide | DePuy Synthes, Baxter International Inc, NuVasive, Smith & Nephew PLC, Medtronic PLC, Orthofix Medical Inc, Zimmer Biomet Holdings Inc, Geistlich Pharma, Stryker Corp, AlloSource, TBF, OST Laboratoires, Biobank |
Other key industry trends
- In terms of revenue, Japan accounted for 2.6% of the global bone grafts and substitutes market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China bone grafts and substitutes market is projected to lead the regional market in terms of revenue in 2030.
- India is the fastest growing regional market in Asia Pacific and is projected to reach USD 194.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bone Grafts And Substitutes Market Scope
Bone Grafts And Substitutes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan bone grafts and substitutes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bone grafts and substitutes market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 92.05% in 2024. Horizon Databook has segmented the Japan bone grafts and substitutes market based on allograft, synthetic covering the revenue growth of each sub-segment from 2018 to 2030.
Japan market is underdeveloped as compared to other countries of Asia pacific region. The stringent regulatory policy creates a barrier for the entry of foreign companies. Only xenograft products are approved in 2012.
Moreover, lack of an established tissue bank is also limiting the growth. The complex registration process and language barrier makes this market very time consuming as compared to other countries. The foreign product should comply with Japan’s Pharmaceutical and Medical Device Law which can be challenging sometimes.
Geistlich held a monopoly position in the market with its xenograft product. Grafton DBM by Medtronic received PMDA approval in August 2018 which is expected to boost the overall bone grafts market of Japan in the coming years.
Reasons to subscribe to Japan bone grafts and substitutes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan bone grafts and substitutes market databook
-
Our clientele includes a mix of bone grafts and substitutes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan bone grafts and substitutes market , including forecasts for subscribers. This country databook contains high-level insights into Japan bone grafts and substitutes market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan bone grafts and substitutes market
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
